Recent Advances in Treating Endometrial and Cervical Cancers - Episode 2
Key opinion leaders review recent updates to the NCCN guidelines for treating recurrent and advanced endometrial cancer, including biomarker testing and targeted therapies like dostarlimab and trastuzumab.